Mustang Bio, Inc. MBIO 深 滬
等待開盤 10-30 09:30:00 美东时间
1.47
-0.030
-2.00%
華盛通- 最 高1.49
- 今 開1.46
- 成交量 5.68万股
- 最 低 1.45
- 昨 收 1.50
- 總市值 1064.22万
- 52周最高 21.945
- 市盈率 靜 --
- 換手率 0.79%
- 52周最低 0.8926
- 委 比 37.28%
- 總股本 723.96万
- 歷史最高 10012.50
- 量 比 0.69
- 振 幅 2.67%
- 歷史最低 1.45
- 每 手 1
- 風險率 3.80%
個股概要
財務分析
公司資料
相關新聞
分紅派息
- 分時圖
- 日k
- 周k
- 月k
相關新聞
更多MindBio Therapeutics Aligns Interests with RSU Issuance Amid Clinical Trial Progress
Mindbio Therapeutics Corp. ( ($TSE:MBIO) ) just unveiled an announcement. MindB...
10-09 05:08
Illinois Pharmacists Can Prescribe PHEXXI Starting January 2026 Under Newly-passed Law
-- Passage of House Bill 3489 allows Illinois pharmacists to prescribe non-hormonal and emergency contraceptives -- -- Ensures a broader range of contraceptive choices is available to women ...
08-21 20:56
Mainz Biomed Announces Pricing of $3.0 Million Follow-On Offering of Ordinary Shares and Warrants
Mainz Biomed announces a $3.0 million follow-on offering of 2,222,222 units at $1.35 per unit, each consisting of one ordinary share or pre-funded warrant and one Series A warrant exercisable at $1.35 per share. The offering, managed by Maxim Group LLC, is set to close on August 5, 2025, pending customary conditions. The securities are registered under SEC's Form F-1 (File No. 333-289095). Investors can obtain the prospectus from Maxim Group.
08-04 14:22
Forvia SE reports 1H results
Forvia SE press release (OTCPK:FURCF): 1H EBITDA increased by €127m and Capex and Capitalized R&D reduced by €232M Revenue of €13.48B (-0.4% Y/Y). Organic growth of 1.1%, driven by Electronics and Sea...
07-28 16:39
12 Health Care Stocks Moving In Monday's Pre-Market Session
Gainers Sonnet BioTherapeutics (NASDAQ:SONN) shares rose 239.4% to $17.55 dur...
07-14 20:08
Calidi Biotherapeutics Stock Jumps 39% After Hours — What's Going On
Calidi Biotherapeutics (NYSE: CLDI) surged 39.47% after hours Tuesday, following renewed investor interest in its innovative cancer treatment developments.
07-09 12:09
Mustang Bio Granted Orphan Drug Designation by U.S. FDA for MB-101 (IL13Ra2-targeted CAR T-cells) to Treat Astrocytomas and Glioblastoma
Mustang Bio's MB-101 CAR-T cell therapy received FDA Orphan Drug Designation for treating recurrent diffuse and anaplastic astrocytoma and glioblastoma. The designation supports the company's strategy to combine MB-101 with MB-108, an oncolytic virus, to enhance efficacy by reshaping the tumor microenvironment. Early data show promising results, including complete responses lasting over 66 months.
07-07 12:30
【美股盘前】特朗普法案连闯两关，市场静候小非农，标指小幅回升，宣布提高股息的银行股上涨，Coinbase涨2%
TradingKey - 7月2日周三美股盘前，三大美股股指期货小幅上涨，标指期货涨0.13%并向纪录高位靠近。科技七巨头盘前多数下跌，参议院通过的特朗普法案的免税条款利好晶片股，但英特尔和美光科技仍跌。监管预期松绑且提高股息的银行股走高，高盛、摩根大通、摩根士丹利等盘前涨近1%。首个SOL质押型ETF在美上市，市场对山寨币ETF夏季热潮预期升温，Coinbase盘前涨近2%。
07-02 12:12
Mustang Bio Designated Orphan Designation Status For "an autologous ex vivo expanded cluster of differentiation 62-enriched naive and memory T-cell investigational product that has been genetically modified using a self-inactivating lentiviral vector to express an IL13Ralpha2-targeted, hinge-optimized, 4-1BB-costimulatory chimeric antigen receptor with a truncated CD19" For The Treatment Of Malignant Glioma
https://www.accessdata.fda.gov/scripts/opdlisting/oopd/detailedIndex.cfm?cfgridkey=1082425
07-01 23:57
MindBio Therapeutics Achieves Milestone in Depression Treatment Trial
Mindbio Therapeutics Corp. ( ($TSE:MBIO) ) has shared an update. MindBio Therap...
06-18 21:42
